Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
- 24 January 2010
- journal article
- review article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 50 (2) , 264-272
Abstract
(Headache 2010;50:264‐272)The US Food and Drug Administration (FDA) have suggested that fatal serotonin syndrome (SS) is possible with selective serotonin reuptake inhibitors (SSRIs) and triptans: this warning affects millions of patients as these drugs are frequently given simultaneously. SS is a complex topic about which there is much misinformation. The misconception that 5‐HT1A receptors can cause serious SS is still widely perpetuated, despite quality evidence that it is activation of the 5‐HT2A receptor that is required for serious SS. This review considers SS involving serotonin agonists: ergotamine, lysergic acid diethylamide, bromocriptine, and buspirone, as well as triptans, and reviews the experimental foundation underpinning the latest understanding of SS. It is concluded that there is neither significant clinical evidence, nor theoretical reason, to entertain speculation about serious SS from triptans and SSRIs. The misunderstandings about SS exhibited by the FDA, and shared by the UK Medicines and Healthcare products Regulatory Agency (in relation to methylene blue), are an important issue with wide ramifications.Keywords
This publication has 61 references indexed in Scilit:
- Drug-induced serotonin syndrome: a reviewExpert Opinion on Drug Safety, 2008
- Indolealkylamines: Biotransformations and Potential Drug–Drug InteractionsThe AAPS Journal, 2008
- Arresting serotoninProceedings of the National Academy of Sciences, 2008
- Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivoProceedings of the National Academy of Sciences, 2008
- The behavioral pharmacology of hallucinogensBiochemical Pharmacology, 2008
- Serotonin Syndrome and Rhabdomyolysis Induced by Concomitant Use of Triptans, Fluoxetine and HypericumCephalalgia, 2007
- Methylene blue implicated in potentially fatal serotonin toxicityAnaesthesia, 2006
- Extracting value from case reports: lessons from serotonin toxicityAnaesthesia, 2006
- Convulsive ergotism: epidemics of the serotonin syndrome?The Lancet Neurology, 2003
- Increase in brain serotonin produced by bromocryptineNeuroscience Letters, 1975